Access the full text.
Sign up today, get DeepDyve free for 14 days.
Y. Cossart (2004)
Human Parvovirus B19American Journal of Transplantation, 4
West Nile virus and the safety of plasma derivatives: verification of high safety
I. Thomas, M. Giambattista, C. Gérard, E. Mathys, V. Hougardy, B. Latour, T. Branckaert, Ruth Laub (2003)
Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non‐structural viral proteinsVox Sanguinis, 84
J. Mori, Pamela Beattie, David Melton, Bernard Cohen, J. Clewley (1987)
Structure and mapping of the DNA of human parvovirus B19.The Journal of general virology, 68 ( Pt 11)
A. Servant, S. Laperche, F. Lallemand, V. Marinho, G. Maur, J. Meritet, A. Garbarg‐Chenon (2002)
Genetic Diversity within Human Erythroviruses: Identification of Three GenotypesJournal of Virology, 76
LI Qihan, A. Yafal, Young Lee, J. Hogle, Marie, '. Chow (1994)
Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperatureJournal of Virology, 68
K. Ozawa, J. Ayub, Y. Hao, G. Kurtzman, T. Shimada, N. Young (1987)
Novel transcription map for the B19 (human) pathogenic parvovirusJournal of Virology, 61
J. Blümel, I. Schmidt, W. Effenberger, H. Seitz, H. Willkommen, H. Brackmann, J. Löwer, A. Eis-Hübinger (2002)
Parvovirus B19 transmission by heat‐treated clotting factor concentratesTransfusion, 42
J. Blümel, I. Schmidt, H. Willkommen, J. Löwer (2002)
Inactivation of parvovirus B19 during pasteurization of human serum albuminTransfusion, 42
C. Spearman
The method of 'right and wrong cases' ('constant stimuli') without Gauss's formulaeBritish Journal of Psychology, 2
T. Kreil, A. Berting, O. Kistner, J. Kindermann (2003)
West Nile virus and the safety of plasma derivatives: verification of high safety margins, and the validity of predictions based on model virus dataTransfusion, 43
R. Laub, P. Strengers (2002)
Parvoviruses and blood products.Pathologie-biologie, 50 5
Quang Nguyen, C. Sifer, V. Schneider, Xavier Allaume, A. Servant, F. Bernaudin, Véronique Auguste, A. Garbarg‐Chenon (1999)
Novel Human Erythrovirus Associated with Transient Aplastic AnemiaJournal of Clinical Microbiology, 37
(2002)
A new parvovirus genotype persistent in skin
Saburo Miyasaki (1931)
Beitrag zur kollektiven Behandlung pharmakologischer ReihenversucheNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 162
Quang Nguyen, Susan Wong, E. Heegaard, K. Brown (2002)
Identification and characterization of a second novel human erythrovirus variant, A6.Virology, 301 2
J. Summers, S. Jones, M. Anderson (1983)
Characterization of the genome of the agent of erythrocyte aplasia permits its classification as a human parvovirus.The Journal of general virology, 64 (Pt 11)
Note for Guidance on Plasma-Derived Medicinal Products
H. Matsui, M. Sugimoto, S. Tsuji, M. Shima, J. Giddings, A. Yoshioka (1999)
Transient hypoplastic anemia caused by primary human parvovirus B19 infection in a previously untreated patient with hemophilia transfused with a plasma-derived, monoclonal antibody-purified factor VIII concentrate.Journal of pediatric hematology/oncology, 21 1
G. Sofer, D. Lister, Jerl Boose (2003)
Virus inactivation in the 1990s -and into the 21st century. Part 6, inactivation methods grouped by virusBiopharm International, 16
(2004)
West Nile virus and the safety of plasma derivatives: verification of high safety BOSCHETTI
J. Fernandes, Damu Tang, G. Leone, P. Lee (1994)
Binding of reovirus to receptor leads to conformational changes in viral capsid proteins that are reversible upon virus detachment.The Journal of biological chemistry, 269 25
B. Kaufmann, A. Simpson, M. Rossmann (2004)
The structure of human parvovirus B19.Proceedings of the National Academy of Sciences of the United States of America, 101 32
H. Lehmann, L. Kühner, K. Beckenlehner, E. Müller-Godeffroy, K. Heide, R. Küster, S. Modrow (2002)
Chronic human parvovirus B19 infection in rheumatic disease of childhood and adolescence.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 25 2
K. Hokynar, M. Söderlund-Venermo, M. Pesonen, A. Ranki, O. Kiviluoto, E. Partio, K. Hedman (2002)
A new parvovirus genotype persistent in human skin.Virology, 302 2
F. Barah, P. Vallely, G. Cleator, J. Kerr (2003)
Neurological manifestations of human parvovirus B19 infectionReviews in Medical Virology, 13
Larry Anderson, Cecilia, Tsou, A. Robert, Parker, L. Terence, Chorba, Herta Wulff, Peter Tattersall, P. Philip, Mortimer (1986)
Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assayJournal of Clinical Microbiology, 24
N. Boschetti, K. Wyss, Anita Mischler, Thomas Hostettler, C. Kempf (2003)
Stability of minute virus of mice against temperature and sodium hydroxide.Biologicals : journal of the International Association of Biological Standardization, 31 3
(2001)
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Information Technology
M. Yunoki, M. Tsujikawa, T. Urayama, Y. Sasaki, M. Morita, H. Tanaka, S. Hattori, K. Takechi, K. Ikuta (2003)
Heat sensitivity of human parvovirus B19Vox Sanguinis, 84
Heegaard (2002)
Human parvovirus B19Clin Microbiol Rev, 15
Ulrike Koenigbauer, T. Eastlund, J. Day (2000)
Clinical illness due to parvovirus B19 infection after infusion of solvent/detergent‐treated pooled plasmaTransfusion, 40
M. Hino, O. Ishiko, K. Honda, T. Yamane, K. Ohta, T. Takubo, N. Tatsumi (2000)
Transmission of symptomatic parvovirus B19 infection by fibrin sealant used during surgeryBritish Journal of Haematology, 108
Eiji Miyagawa, T. Yoshida, Hirohiko Takahashi, K. Yamaguchi, Tohko Nagano, Yoshiko Kiriyama, Kazuo Okochi, Hiroyuki Sato (1999)
Infection of the erythroid cell line, KU812Ep6 with human parvovirus B19 and its application to titration of B19 infectivity.Journal of virological methods, 83 1-2
BACKGROUND: Parvoviridae are small nonenveloped viruses that are known to be highly resistant to physico‐chemical treatments. Because low pH is frequently applied to process intermediates or final products, the impact of such conditions on the human erythrovirus B19 (B19V) and the mouse parvovirus (mice minute virus, MMV) was assessed, which is often used as a model for B19V. Owing to the lack of a suitable cultivation and/or detection system for B19V no such data exist so far. STUDY DESIGN AND METHODS: Virus inactivation was monitored by decrease of infectivity and loss of capsid integrity. Infectious B19V was quantified by dete‐ction of virus‐specific messenger RNA from Ku812Ep6 cells. To measure capsid integrity, endonucleases were added after exposure to low pH and the encapsidated (endonuclease‐protected) virus DNA was quantified by real‐time PCR. RESULTS: B19V was inactivated greater than 5 log after 2 hours at pH 4, whereas MMV was resistant over 9 hours. Infectivity data strongly correlated with data obtained by the endonuclease assay. Capsid disintegra‐tion was observed in immunoglobulin G as well as in different albumin solutions. Temperature and pH showed concerted impact on B19V capsid disintegration. CONCLUSION: Our data show that B19V is much more vulnerable toward low pH conditions than MMV. Together with the previously reported susceptibility of B19V toward wet heat conditions, low pH is the second treatment where erythrovirus B19V is less resistant than viruses from the parvovirus genus.
Transfusion – Wiley
Published: Jul 1, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.